Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Director Acquires $58,700.00 in Stock
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) Director John B. Bode bought 10,000 shares of the firm’s stock in a transaction on Friday, July 12th. The stock was purchased at an average cost of $5.87 per share, with a total value of $58,700.00. Following the completion of the transaction, the director now directly owns […]
More Stories
Ripio Credit Network (RCN) Price Reaches $0.0017 on Major Exchanges
Ripio Credit Network (RCN) traded up 1.1% against the dollar during the 24 hour period ending at 15:00 PM E.T....
Fortrea (NASDAQ:FTRE) Hits New 1-Year Low – Here’s What Happened
Fortrea Holdings Inc. (NASDAQ:FTRE – Get Free Report) shares reached a new 52-week low on Wednesday . The company traded...
Community Health Systems (NYSE:CYH) Trading 7.3% Higher – Here’s Why
Shares of Community Health Systems, Inc. (NYSE:CYH – Get Free Report) shot up 7.3% on Wednesday . The stock traded...
SPDR Portfolio S&P 500 Value ETF (NYSEARCA:SPYV) Sees Large Volume Increase – Still a Buy?
SPDR Portfolio S&P 500 Value ETF (NYSEARCA:SPYV – Get Free Report) saw unusually-strong trading volume on Wednesday . Approximately 7,465,729...
Stelmine Canada (CVE:STH) Sets New 1-Year Low – Time to Sell?
Stelmine Canada Ltd. (CVE:STH – Get Free Report) shares hit a new 52-week low on Wednesday . The stock traded...
Avation (LON:AVAP) Reaches New 12-Month High – Time to Buy?
Avation PLC (LON:AVAP – Get Free Report)’s share price hit a new 52-week high during trading on Wednesday . The...